AIkido Pharma
Financial ratios & Valuation

Historical Multiples (2013 – 2022)

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-0.59-0.00-0.00-0.00-0.020.07-0.04-0.11-0.19-0.63-1.140.07
Price/Sales ratio
393.621.760.870.070.074.9020.18N/AN/AN/AN/A4.90
Price/Book Value ratio
0.220.000.000.010.020.010.010.040.000.250.230.02
Price/Cash Flow ratio
-2.01-0.00-0.000.89-0.02-0.05-0.06-0.35-0.14-1.79-2.17-0.05
Price/Free Cash Flow ratio
-1.46-0.00-0.000.95-0.03-0.04-0.05-0.26-0.14-1.79-2.05-0.04
Price/Earnings Growth ratio
-0.180.00-0.000.000.00-0.000.000.000.00-0.00-0.02-0.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
88.88%-8540%-166.66%90.42%92.55%-189.28%100%N/AN/AN/AN/A-189.28%
Operating Profit Margin
-56840.74%-306110%-157606.06%-975.02%-309.22%-24550%-63166.66%N/AN/AN/AN/A-309.22%
Pretax Profit Margin
-66537.03%-305320%-155954.54%-738.42%-267.47%6167.85%-46477.77%N/AN/AN/AN/A-267.47%
Net Profit Margin
-66537.03%-305320%-155954.54%-738.42%-267.47%6167.85%-46477.77%N/AN/AN/AN/A-267.47%
Effective Tax Rate
N/A-0.25%-1.05%-32.04%-15.60%498.03%N/AN/A31.65%-35.10%N/A-15.60%
Return on Assets
-25.71%-49.92%-375.82%-57.42%-36.84%13.03%-37.07%-40.45%-4.77%-39.17%-19.72%-36.84%
Return On Equity
-37.19%-56.97%-588.17%-121.77%-80.51%14.27%-39.71%-41.65%-4.82%-40.48%-17.17%-80.51%
Return on Capital Employed
-22.45%-51.07%-563.00%-99.34%-59.77%-56.81%-53.97%-22.10%-9.29%-19.27%-16.70%-59.77%
Liquidity Ratios
Current Ratio
2.173.580.862.351.682.511.5031.62N/AN/A29.531.68
Quick Ratio
2.073.580.862.351.682.511.5031.6285.6628.3126.961.68
Cash ratio
2.070.650.030.050.070.010.123.0961.7918.5418.160.07
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
32.85K307.541.59K534.46222.17594.81N/AN/AN/AN/AN/A594.81
Cash Conversion Cycle
-32.85K-307.54-1.59K-534.46-222.17-594.81N/AN/AN/AN/AN/A-222.17
Debt Ratios
Debt Ratio
0.300.000.020.020.00N/AN/AN/AN/A0.000.030.00
Debt Equity Ratio
0.440.010.040.040.01N/AN/AN/AN/A0.000.030.01
Long-term Debt to Capitalization
N/A0.000.020.00N/AN/AN/AN/AN/AN/A0.00N/A
Total Debt to Capitalization
N/A0.010.040.040.01N/AN/AN/AN/A0.000.00N/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-23.52N/A
Cash Flow to Debt Ratio
N/A-16.40-11.350.30-68.16N/AN/AN/AN/A-129.23-11.75-68.16
Company Equity Multiplier
1.441.141.562.122.181.091.071.021.011.031.031.09
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-195.18-951.6-1400.07-2.64-97.46-335.22N/AN/AN/AN/A-2.64
Free Cash Flow / Operating Cash Flow Ratio
1.371.101.000.940.791.011.111.36111.060.79
Cash Flow Coverage Ratio
N/A-16.40-11.350.30-68.16N/AN/AN/AN/A-129.23-11.75-68.16
Short Term Coverage Ratio
N/A-55.00-25.950.38-68.16N/AN/AN/AN/A-129.23-208.02N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A